治疗前18F-FDG PET/CT影像组学预测早期非小细胞肺癌SBRT后局部复发:多中心研究
该回顾性多中心研究 pooled 3个中心(n=27、29、8)为训练集,第4个中心(n=23)为测试集,提取184个IBSI兼容的影像组学特征,用ComBat协调4个机构不同PET/CT扫描仪的特征。结果显示2个PET特征(Information Correlation 2和strength)组合模型在测试集准确率0.91(敏感性100%,特异性81%,HR未定义,P=0.023),而仅CT特征或PET+CT组合模型未能在测试集验证。
要点
- 2个PET影像组学特征与SBRT后局部控制独立相关,可组合为预测模型。
- 最佳训练集模型(PET Information Correlation 2+CT flatness)敏感性100%、特异性96%。
- 仅CT特征或PET+CT组合模型在测试集未验证成功。
核心结论
- 2个源自18F-FDG PET的影像组学特征与非小细胞肺癌SBRT后局部控制独立相关,可组合为准确预测模型。
研究设计与样本
- 回顾性多中心研究,训练集来自3个中心(n=27、29、8)pooled,测试集来自第4个中心(n=23)。
- 主要终点为局部控制,PET图像用模糊局部自适应贝叶斯算法半自动勾画原发肿瘤,低剂量CT手动勾画。
- 提取184个IBSI兼容影像组学特征,纳入7个临床和治疗参数,用ComBat协调4个机构不同PET/CT扫描仪的特征。
主要发现
- 训练集中位随访21.1个月(范围1.7-63.4个月),测试集中位随访25.5个月(范围7.7-57.8个月)。
- 单因素分析中无临床变量显著预测局部控制,2个PET特征和2个CT特征显著。
- 训练集最佳模型组合PET Information Correlation 2和CT flatness,敏感性100%、特异性96%。
- 另一模型组合PET Information Correlation 2和strength,敏感性100%、特异性88%,HR未定义(P<0.001)。
- 后一模型在测试集准确率0.91(敏感性100%、特异性81%),HR未定义(P=0.023)。
关键数值与推荐
- 训练集最佳模型:PET Information Correlation 2+CT flatness,敏感性100%、特异性96%。
- 训练集PET双特征模型:Information Correlation 2+strength,敏感性100%、特异性88%,HR未定义(P<0.001)。
- 测试集PET双特征模型:准确率0.91(敏感性100%、特异性81%),HR未定义(P=0.023)。
临床怎么用
- 治疗前18F-FDG PET影像组学模型可提供局部复发相关信息,辅助SBRT临床决策。
- 仅CT特征或PET+CT组合模型未在测试集验证,临床应优先关注PET来源的2个特征。
局限性
- 仅PET双特征模型在测试集验证成功,其他模型未验证。
- 原文未报告模型的风险比具体数值(HR未定义)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this retrospective multicentric study was to develop and evaluate a prognostic 18F-FDG PET/CT radiomic signature in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy (SBRT). Methods: Patients from 3 different centers (n = 27, 29, and 8) were pooled to constitute the training set, whereas the patients from a fourth center (n = 23) were used as the testing set. The primary endpoint was local control. The primary tumor was semiautomatically delineated in the PET images using the fuzzy locally adaptive Bayesian algorithm, and manually in the low-dose CT images. In total, 184 Image Biomarkers Standardization Initiative-compliant radiomic features were extracted. Seven clinical and treatment parameters were included. We used ComBat to harmonize radiomic features extracted from the 4 institutions relying on different PET/CT scanners. In the training set, variables found significant in the univariate analysis were fed into a multivariate regression model, and models were built by combining independent prognostic factors. Results: Median follow-up was 21.1 mo (range, 1.7-63.4 mo) and 25.5 mo (range, 7.7-57.8 mo) in training and testing sets, respectively. In univariate analysis, none of the clinical variables, 2 PET features, and 2 CT features were significantly predictive of local control. The best predictive models in the training set were obtained by combining one feature from PET (Information Correlation 2) and one feature from CT (flatness), reaching a sensitivity of 100% and a specificity of 96%. Another model combining 2 PET features (Information Correlation 2 and strength) reached sensitivity of 100% and specificity of 88%, both with an undefined hazard ratio (P < 0.001). The latter model obtained an accuracy of 0.91 (sensitivity, 100%; specificity, 81%), with a hazard ratio undefined (P = 0.023) in the testing set; however, other models relying on CT radiomic features only or the combination of PET and CT features failed to validate in the testing set. Conclusion: We showed that 2 radiomic features derived from 18F-FDG PET were independently associated with local control in patients with non-small cell lung cancer undergoing SBRT and could be combined in an accurate predictive model. This model could provide local relapse-related information and could be helpful in clinical decision making.
引用
- Dissaux G, Visvikis D, Da-Ano R, et al. Pretreatment 18F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multicentric Study. J Nucl Med. 2019. PMID: 31732678. doi:10.2967/jnumed.119.228106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。